HedgeChatter

  • Home /
  • Tag Archives

AMRN

GW Appoints Stephen D. Schultz as Vice President of Investor Relations

[at noodls] – 19 March 2013 Porton Down, UK; March 19 2013: GW Pharmaceuticals plc (AIM:GWP) today announced the appointment of Stephen D. Schultz to the new role of Vice President, Investor Relations. Mr. Schultz will … moreView todays social media effects on AMRNView the latest stocks trending across Twitter. Click to view dashboardSee who Amarin is hiring next, click […]

March 19, 2013 Bystocknews , Comments Off on GW Appoints Stephen D. Schultz as Vice President of Investor Relations read more

Amarin Reports Fourth Quarter and Year-End 2012 Financial Results and Provides Update on Operations

[at noodls] – BEDMINSTER, N.J. and DUBLIN, Ireland, Feb. 28, 2013 (GLOBE NEWSWIRE) — Amarin Corporation plc (Nasdaq:AMRN), a late-stage biopharmaceutical company focused on the commercialization and development of … moreView todays social media effects on AMRNView the latest stocks trending across Twitter. Click to view dashboardSee who Amarin is hiring next, click here to view […]

February 28, 2013 Bystocknews , Comments Off on Amarin Reports Fourth Quarter and Year-End 2012 Financial Results and Provides Update on Operations read more

Amarin to Report Fourth Quarter and Year-End 2012 Results and Host Conference Call on February 28, 2013

[at noodls] – BEDMINSTER, N.J., and DUBLIN, Ireland, Feb. 22, 2013 (GLOBE NEWSWIRE) — Amarin Corporation plc (Nasdaq:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics … moreView todays social media effects on AMRNView the latest stocks trending across Twitter. Click to view dashboardSee who Amarin is hiring next, click here to view […]

February 22, 2013 Bystocknews , Comments Off on Amarin to Report Fourth Quarter and Year-End 2012 Results and Host Conference Call on February 28, 2013 read more

Amarin to Present at the CITI 2013 Global Healthcare Conference

[at noodls] – BEDMINSTER, N.J., and DUBLIN, Ireland, Feb. 21, 2013 (GLOBE NEWSWIRE) — Amarin Corporation plc (Nasdaq:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics … moreView todays social media effects on AMRNView the latest stocks trending across Twitter. Click to view dashboardSee who Amarin is hiring next, click here to view […]

February 21, 2013 Bystocknews , Comments Off on Amarin to Present at the CITI 2013 Global Healthcare Conference read more

Amarin Announces Notification of Patent Allowance for U.S. Application 13/614,129 Related to Vascepa(R) and FDA Approved MARINE Indication

[at noodls] – BEDMINSTER, N.J. and DUBLIN, Ireland, Feb. 12, 2013 (GLOBE NEWSWIRE) — Amarin Corporation plc (Nasdaq:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics … moreView todays social media effects on AMRNView the latest stocks trending across Twitter. Click to view dashboardSee who Amarin is hiring next, click here to view […]

February 12, 2013 Bystocknews , Comments Off on Amarin Announces Notification of Patent Allowance for U.S. Application 13/614,129 Related to Vascepa(R) and FDA Approved MARINE Indication read more

Amarin Announces Notification of Patent Allowance for U.S. Application 13/614,146 Related to Vascepa(R) and FDA Approved MARINE Indication

[at noodls] – BEDMINSTER, N.J., and DUBLIN, Ireland, Feb. 7, 2013 (GLOBE NEWSWIRE) — Amarin Corporation plc (Nasdaq:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics … moreView todays social media effects on AMRNView the latest stocks trending across Twitter. Click to view dashboardSee who Amarin is hiring next, click here to view […]

February 7, 2013 Bystocknews , Comments Off on Amarin Announces Notification of Patent Allowance for U.S. Application 13/614,146 Related to Vascepa(R) and FDA Approved MARINE Indication read more

Amarin Announces Market Introduction of Vascepa(R) (icosapent ethyl) Capsules for the Treatment of Very High Triglycerides (VHTG)

[at noodls] – -First and Only FDA Approved Pure-EPA Omega-3 Prescription Therapy Now Available- -Vascepa Reduces VHTG Without Raising LDL Cholesterol- BEDMINSTER, N.J., and DUBLIN, Ireland, Jan. 24, 2013 (GLOBE NEWSWIRE) … moreView todays social media effects on AMRNView the latest stocks trending across Twitter. Click to view dashboardSee who Amarin is hiring next, click here to view […]

January 24, 2013 Bystocknews , Comments Off on Amarin Announces Market Introduction of Vascepa(R) (icosapent ethyl) Capsules for the Treatment of Very High Triglycerides (VHTG) read more

Amarin Announces First Notification of U.S. Patent Allowance Based on ANCHOR Clinical Trial Results

[at noodls] – BEDMINSTER, N.J. and DUBLIN, Ireland, Jan. 23, 2013 (GLOBE NEWSWIRE) — Amarin Corporation plc (Nasdaq:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics … moreView todays social media effects on AMRNView the latest stocks trending across Twitter. Click to view dashboardSee who Amarin is hiring next, click here to view […]

January 23, 2013 Bystocknews , Comments Off on Amarin Announces First Notification of U.S. Patent Allowance Based on ANCHOR Clinical Trial Results read more

Amarin to Present at the 31st Annual J.P. Morgan Healthcare Conference

[at noodls] – BEDMINSTER, N.J., and DUBLIN, Ireland, Jan. 2, 2013 (GLOBE NEWSWIRE) — Amarin Corporation plc (Nasdaq:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics … moreView todays social media effects on AMRNView the latest stocks trending across Twitter. Click to view dashboardSee who Amarin is hiring next, click here to view […]

January 2, 2013 Bystocknews , Comments Off on Amarin to Present at the 31st Annual J.P. Morgan Healthcare Conference read more

Amarin Announces Notification of Patent Allowance for U.S. Application 13/623,450 Related to Vascepa(R) and FDA Approved MARINE Indication

[at noodls] – BEDMINSTER, N.J., and DUBLIN, Ireland, Dec. 13, 2012 (GLOBE NEWSWIRE) — Amarin Corporation plc (Nasdaq:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics … moreView todays social media effects on AMRNView the latest stocks trending across Twitter. Click to view dashboardSee who Amarin is hiring next, click here to view […]

December 13, 2012 Bystocknews , Comments Off on Amarin Announces Notification of Patent Allowance for U.S. Application 13/623,450 Related to Vascepa(R) and FDA Approved MARINE Indication read more